Therapeutic Area

Analgesic

Therapeutic area intelligence for Analgesic with 10 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 10
Catalysts: 0
Companies: 6

Companies

Amneal Pharmaceuticals →

CIPHER PHARMS INC. →

Micro Labs Ltd India →

Strides Pharma →

Sun Pharma →

Sun Pharmaceutical Industries →

Assets

CONZIP →

FDA →

Rosemont →

Recent signals(10)

RegulatoryJune 29, 2026

FDA Approval Status Update for Tramadol Hydrochloride and Acetaminophen

The FDA has provided an approval status update for the ANDA201952 application for Tramadol Hydrochloride and Acetaminophen submitted by Micro Labs Ltd India.

RegulatoryJune 29, 2026

FDA Approval Letter for Tramadol Hydrochloride by Sun Pharma

The FDA has issued an approval letter for the ANDA076100 application for Tramadol Hydrochloride submitted by Sun Pharma.

RegulatoryJune 28, 2026

FDA Approval for Tramadol Hydrochloride and Acetaminophen Combination

The FDA has approved the ANDA077858 application for a combination of Tramadol Hydrochloride and Acetaminophen.

RegulatoryJune 28, 2026

FDA Approval Update for Tramadol Hydrochloride Supplement by Strides Pharma

Strides Pharma International has received an approval status for the supplemental application of Tramadol Hydrochloride.

StrategyJune 27, 2026

FDA Approval Letter for Tramadol Hydrochloride by Sun Pharma

The FDA has issued an approval letter for the ANDA075964 application for Tramadol Hydrochloride submitted by Sun Pharmaceutical Industries.

RegulatoryJune 26, 2026

FDA Approves Supplemental NDA for QDOLO (Tramadol Hydrochloride)

The FDA has approved a supplemental NDA for QDOLO, which contains tramadol hydrochloride.

RegulatoryJune 26, 2026

FDA Approval Update for Tramadol Hydrochloride by Graviti Pharms

The FDA has updated the application status for Tramadol Hydrochloride submitted by Graviti Pharms to AP.

RegulatoryJune 26, 2026

FDA Approves Supplemental Application for CONZIP (Tramadol Hydrochloride)

The FDA has approved a supplemental application for CONZIP, which contains tramadol hydrochloride.

RegulatoryJune 25, 2026

FDA Approval for Amneal's Tramadol Hydrochloride Supplement

The FDA has granted approval for Amneal Pharmaceuticals' supplemental application for Tramadol Hydrochloride.

RegulatoryJune 24, 2026

FDA Approval for Tramadol Hydrochloride Supplement by Sun Pharma

The FDA has approved a supplement application for Tramadol Hydrochloride submitted by Sun Pharma.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.